© 2026 Michigan State University Board of Trustees
Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Why FDA approval of sickle cell gene therapy is a ‘big deal’

Season 2023 Episode 354 | 5m 08s

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.

Major corporate funding for the PBS News Hour is provided by BDO, BNSF, Consumer Cellular, American Cruise Lines, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Consumer Cellular and Cunard Cruise Line. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.
Extras
'This is my home,' says DACA recipient deported then returned to U.S.
News Wrap: Wildfires threaten homes in southern Georgia
What marijuana’s reclassification means for public health and businesses
‘America First’ aid policy reshapes how U.S. delivers global health assistance
State Department proposes sending Afghans who helped U.S. war effort to Congo
Art exhibition shines light on Romani persecution during Holocaust
April 23, 2026 - PBS News Hour full episode
April 22, 2026 - PBS News Hour full episode
RFK Jr. defends vaccine guidance changes and health spending cuts
Election officials sound alarm over political interference in midterms